SLEEP: Next Steps

The journal SLEEP has increased its impact factor to 6.3. Ron Szymusiak and the previous editorial team are to be congratulated for this increase. It places SLEEP as the leading journal in the field of sleep/circadian studies focused on original research. The areas of interest for this journal are broad, including basic research, translational research, clinical research, and implementation science. We have a strong portfolio in sleep epidemiology and public health and a growing number of manuscripts published in the area of genetics. As the leading journal for original research in sleep and circadian research, SLEEP has a major responsibility for our field. Our new editorial team of David Gozal (senior Deputy Editor), Antoine Adamantidis (Deputy Editor), and Katie Stone (Deputy Editor) take this responsibility very seriously. We are introducing a number of important changes to our journal. We are introducing new standards for clinical research articles we publish. For example, we will adhere to CONSORT guidelines for randomized trials. Based on the Declaration of Helsinki (2008), we will ensure that clinical trials are registered before they start. Authors will be required to submit the appropriate checklist with their original article. Similarly for other types of clinical research articles we will use the most appropriate guidelines recommended by the EQUATOR Network (www.equator-network.org).